Glaukos ROE 2014-2023 | GKOS
Glaukos ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2023-12-31 | $-0.14B | $0.46B | -27.86% |
2023-09-30 | $-0.13B | $0.48B | -25.72% |
2023-06-30 | $-0.13B | $0.49B | -24.46% |
2023-03-31 | $-0.14B | $0.51B | -26.05% |
2022-12-31 | $-0.10B | $0.53B | -17.87% |
2022-09-30 | $-0.09B | $0.55B | -15.85% |
2022-06-30 | $-0.06B | $0.56B | -9.71% |
2022-03-31 | $-0.03B | $0.60B | -4.73% |
2021-12-31 | $-0.05B | $0.59B | -8.30% |
2021-09-30 | $-0.04B | $0.60B | -6.22% |
2021-06-30 | $-0.06B | $0.58B | -9.59% |
2021-03-31 | $-0.08B | $0.59B | -12.86% |
2020-12-31 | $-0.12B | $0.67B | -18.39% |
2020-09-30 | $-0.07B | $0.66B | -11.07% |
2020-06-30 | $-0.07B | $0.66B | -13.11% |
2020-03-31 | $-0.04B | $0.64B | -8.75% |
2019-12-31 | $0.02B | $0.67B | 5.18% |
2019-09-30 | $-0.02B | $0.19B | -10.31% |
2019-06-30 | $-0.01B | $0.19B | -6.76% |
2019-03-31 | $-0.01B | $0.19B | -6.56% |
2018-12-31 | $-0.01B | $0.17B | -8.27% |
2018-09-30 | $-0.01B | $0.16B | -9.44% |
2018-06-30 | $-0.01B | $0.15B | -4.27% |
2018-03-31 | $-0.00B | $0.14B | -2.97% |
2017-12-31 | $0.00B | $0.14B | 0.00% |
2017-09-30 | $-0.00B | $0.13B | -0.80% |
2017-06-30 | $-0.00B | $0.13B | -0.84% |
2017-03-31 | $0.00B | $0.12B | 3.52% |
2016-12-31 | $0.00B | $0.12B | 3.72% |
2016-09-30 | $0.00B | $0.11B | 1.96% |
2016-06-30 | $-0.00B | $0.11B | -1.02% |
2016-03-31 | $-0.04B | $0.10B | -36.55% |
2015-12-31 | $-0.04B | $0.10B | -52.67% |
2015-09-30 | $-0.04B | $0.10B | -87.91% |
2015-06-30 | $-0.04B | $0.10B | -179.31% |
2015-03-31 | $-0.01B | $-0.00B | 450.00% |
2014-12-31 | $-0.01B | $-0.00B | 1200.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $5.024B | $0.315B |
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $218.237B | 26.44 |
Intuitive Surgical (ISRG) | United States | $132.348B | 79.73 |
DexCom (DXCM) | United States | $54.655B | 83.14 |
Edwards Lifesciences (EW) | United States | $52.976B | 34.51 |
IQVIA Holdings (IQV) | United States | $42.467B | 25.19 |
IDEXX Laboratories (IDXX) | United States | $40.633B | 48.58 |
Alcon (ALC) | Switzerland | $38.876B | 28.67 |
STERIS (STE) | Ireland | $19.915B | 23.57 |
Waters (WAT) | United States | $18.288B | 26.24 |
Hologic (HOLX) | United States | $17.772B | 19.61 |
SONOVA HOLDING (SONVY) | Switzerland | $16.481B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.303B | 85.01 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.860B | 14.65 |
Sysmex ADR (SSMXY) | Japan | $9.975B | 31.28 |
Teleflex (TFX) | United States | $9.736B | 15.29 |
Penumbra (PEN) | United States | $7.965B | 98.32 |
Masimo (MASI) | United States | $7.156B | 40.13 |
Globus Medical (GMED) | United States | $6.819B | 21.62 |
Integer Holdings (ITGR) | United States | $3.724B | 22.50 |
LivaNova (LIVN) | United Kingdom | $2.973B | 19.61 |
TransMedics (TMDX) | United States | $2.920B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $2.687B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.570B | 17.63 |
Nihon Kohden (NHNKY) | Japan | $2.380B | 20.13 |
Tandem Diabetes Care (TNDM) | United States | $2.296B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $2.233B | 9.16 |
Inari Medical (NARI) | United States | $2.207B | 380.70 |
RxSight (RXST) | United States | $1.919B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.689B | 0.00 |
Veracyte (VCYT) | United States | $1.462B | 0.00 |
OPKO Health (OPK) | United States | $0.850B | 0.00 |
Artivion (AORT) | United States | $0.835B | 96.52 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.825B | 15.26 |
Paragon 28 (FNA) | United States | $0.744B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.712B | 0.00 |
Silk Road Medical (SILK) | United States | $0.691B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.636B | 0.00 |
SiBone (SIBN) | United States | $0.586B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.549B | 18.65 |
IRadimed (IRMD) | United States | $0.525B | 30.49 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.490B | 0.00 |
Nevro (NVRO) | United States | $0.426B | 0.00 |
NeuroPace (NPCE) | United States | $0.373B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.370B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.369B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.339B | 11.42 |
CVRx (CVRX) | United States | $0.311B | 0.00 |
AxoGen (AXGN) | United States | $0.285B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.275B | 0.00 |
Sight Sciences (SGHT) | United States | $0.255B | 0.00 |
AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
Accuray (ARAY) | United States | $0.216B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.190B | 0.00 |
908 Devices (MASS) | United States | $0.183B | 0.00 |
Semler Scientific (SMLR) | United States | $0.182B | 9.81 |
Alpha Tau Medical (DRTS) | Israel | $0.167B | 0.00 |
Inogen (INGN) | United States | $0.153B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.144B | 0.00 |
Delcath Systems (DCTH) | United States | $0.134B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
Neuronetics (STIM) | United States | $0.106B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.100B | 0.00 |
Envoy Medical (COCH) | United States | $0.099B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.093B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.075B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
Hyperfine (HYPR) | United States | $0.060B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.055B | 111.00 |
Vasomedical (VASO) | United States | $0.052B | 9.33 |
Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
InspireMD (NSPR) | Israel | $0.045B | 0.00 |
DarioHealth (DRIO) | United States | $0.044B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
LENSAR (LNSR) | United States | $0.039B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.032B | 0.00 |
Spectral AI (MDAI) | United States | $0.032B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
PAVmed (PAVM) | United States | $0.016B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
NexGel (NXGL) | United States | $0.014B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Microbot Medical (MBOT) | United States | $0.012B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.005B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
Dynatronics (DYNT) | United States | $0.003B | 0.00 |
Tenon Medical (TNON) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |